Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis

被引：0
|
作者：
Gore, M. E.
Porta, C.
Oudard, S.
Bjarnason, G.
Castellano, D.
Szczylik, C.
Mainwaring, P. N.
Schoffski, P.
Rini, B. I.
Bukowski, R. M.
机构：
[1] Royal Marsden Hosp NHS Trust, London, England
[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[3] Hop Europeen Georges Pompidou, Paris, France
[4] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Mil Inst Med, Warsaw, Poland
[7] Mater Adult Hosp, South Brisbane, Australia
[8] Leuven Canc Inst, Leuven, Belgium
[9] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5010
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of sunitinib (S) and temsirolimus (T) in metastatic renal cell carcinoma (mRCC)
    Campbell, Matthew T.
    Millikan, Randall E.
    Altinmakas, Emre
    Xiao, Lianchun
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [32] Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)
    Molina, A. M.
    Feldman, D. R.
    Ginsberg, M. S.
    Fischer, P.
    Trinos, M. J.
    Patil, S.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [33] Sunitinib safety and tolerability in patients with metastatic renal cell carcinoma (MRCC)
    Ferrari, A.
    Sabbatini, R.
    Maur, M.
    Giovannelli, S.
    Jovic, G.
    Conte, P.
    ANNALS OF ONCOLOGY, 2006, 17 : XI83 - XI83
  • [34] Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy
    Lee, Se-Hoon
    Bang, Yung-Jue
    Mainwaring, Paul
    Ng, Christina
    Chang, John W-C
    Kwong, Philip
    Li, Rubi K.
    Sriuranpong, Virote
    Toh, Chee-Keong
    Yuan, Jinyu
    Pitman Lowenthal, Susan
    Chung, Hyun C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 237 - 245
  • [35] Central and Eastern European experience with sunitinib in metastatic renal cell carcinoma: a sub-analysis of the Global Expanded-Access Trial
    Vrdoljak, Eduard
    Geczi, Lajos
    Mardiak, Jozef
    Ciuleanu, Tudor-Eliade
    Leyman, Sophie
    Zhang, Ke
    Sajben, Peter
    Torday, Laszlo
    ONKOUROLOGIYA, 2015, 11 (03): : 101 - 107
  • [36] Central and Eastern European Experience with Sunitinib in Metastatic Renal Cell Carcinoma: A Sub-analysis of the Global Expanded-Access Trial
    Vrdoljak, Eduard
    Geczi, Lajos
    Mardiak, Jozef
    Ciuleanu, Tudor-Eliade
    Leyman, Sophie
    Zhang, Ke
    Sajben, Peter
    Torday, Laszlo
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 775 - 782
  • [37] Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
    Barrios, Carlos H.
    Herchenhorn, Daniel
    Chacon, Matias
    Cabrera-Galeana, Paula
    Sajben, Peter
    Zhang, Ke
    ONCOTARGETS AND THERAPY, 2016, 9 : 5839 - 5845
  • [38] Predictive biomarkers in metastatic Renal Cell Carcinoma (mRCC) patients treated with neoadjuvant sunitinib (PREINSUT trial)
    Mauge, L.
    Pereira, H.
    Gille, A. S.
    Bouaboula, M.
    Grine, A.
    Elaidi, R. T.
    Tartour, E.
    Fournier, L.
    Oudard, S.
    Helley, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S34 - S34
  • [39] Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Feldman, D. R.
    Kondagunta, G. V.
    Ronnen, E. A.
    Fischer, P.
    Chang, R.
    Baum, M.
    Ginsberg, M. S.
    Ishill, N.
    Patil, S.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] A pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (mRCC)
    Hutson, T. E.
    Bukowski, R.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    BJU INTERNATIONAL, 2012, 109 : 5 - 6
12345